MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
30.30
-1.42
-4.48%
Pre Market: 30.76 +0.46 +1.52% 04:29 05/15 EDT
OPEN
31.60
PREV CLOSE
31.72
HIGH
32.46
LOW
30.04
VOLUME
400
TURNOVER
0
52 WEEK HIGH
39.71
52 WEEK LOW
12.11
MARKET CAP
481.55M
P/E (TTM)
-23.4866
1D
5D
1M
3M
1Y
5Y
1D
Analyst Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target Amid Pipeline Progress and 2028 Cash Runway
TipRanks · 1d ago
These Analysts Just Made A Huge Downgrade To Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Forecasts
Simply Wall St · 2d ago
Assembly Bio to present topline Phase 1a data for HDV entry inhibitor ABI-6250 at EASL 2026
PUBT · 2d ago
Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
Barchart · 2d ago
Analysts Have Lowered Expectations For Assembly Biosciences, Inc. (NASDAQ:ASMB) After Its Latest Results
Simply Wall St · 3d ago
Assembly Bio to present at BofA Securities Global Health Care Conference
PUBT · 3d ago
Guggenheim Sticks to Its Buy Rating for Assembly Biosciences (ASMB)
TipRanks · 3d ago
Weekly Report: what happened at ASMB last week (0504-0508)?
Weekly Report · 4d ago
More
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.